Pioglitazone
- Product NDC
- 68071-4959
- 11-digit product format
- 680714959
- Labeler code
- 68071
- Product ID
- 68071-4959_bb9f9ea2-f538-2ce5-e053-2a95a90aa5eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA077210
- Marketing category
- ANDA
- Marketing start
- 2015-02-04
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4959-3 | 68071495903 | 30 TABLET in 1 BOTTLE (68071-4959-3) | 30 tablet | 2019-07-05 | 0000-00-00 | No | No | Current |